logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
20/08/2025
Russian Embassy in India: Despite changes in the political situation, India's oil imports will remain at roughly the same level.
Latest
1 m ago
Tonghua Jinma: Net profit for the first half of 2025 increased by 34.77% year-on-year.
2 m ago
According to a report released by Open Source Securities on August 20, each quick AI newsletter gives Jingrui Pharmaceuticals (600285.SH) a buy rating. The main reasons for this rating include: 1) Completion of external expansion mergers to promote the creation of a second growth curve; 2) Continuous strengthening of research and development innovation to enhance brand power. (Daily Economic News)
2 m ago
Baiyang Pharmaceuticals: Controlling shareholder to increase capital and expand shares, leading to proposed changes in ownership structure.
2 m ago
Da Sin Bank Group (02356.HK) announces its interim performance. Shareholders' attributable profit increased by 13.1% year-on-year to HK$1.579 billion.
3 m ago
Aero Energy: The company's technology and products do not involve AIDC
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.